港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

麥科醫藥-B

28.420

+0.1000.35%

成交量：26.56萬

成交額：753.55萬

市值：94.28億

市盈率：- -

高：28.760

開：28.300

低：28.060

收：28.320

52周最高：45.040

52周最低：27.000

股本：3.32億

香港流通股本：2.80億

量比：0.64

換手率：0.09%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：-33.17%

市淨率：-8.31

市盈率(LYR):- -

市銷率: 27585.63

資料載入中...

總覽公司新聞資訊公告

麥科醫藥-B(02335)存倉市值總計5.21億港元股東將1773.41萬股股票存入Merrill Lynch Far East

麥科醫藥-B(02335)獲納入恒生綜合指數成份股

麥科醫藥-B（02335）將於9月7日納入恒生綜合指數

陝西麥科醫藥科技（02335.HK）將於2026年9月7日納入恒生綜合指數

麥科醫藥－Ｂ(02335)股價上升5.145%，現價港幣$31.88

阿斯达克财经

港股異動 | 麥科醫藥-B(02335)午後漲近6% 創新藥XTL6001三登國際頂級學術舞台

麥科醫藥(02335.HK)XTL6001研究獲接納於公認學術會議作報告

阿斯达克财经

麥科醫藥-B（02335）主要產品XTL6001研究成果獲EASD 2026及ASN Kidney Week 2026收錄

麥科醫藥-B(02335.HK)：XTL6001的研究獲接納於EASD 2026及ASN KIDNEY WEEK 2026作報告

麥科醫藥-B(02335.HK)8月28日舉行董事會會議批准中期業績

麥科醫藥-B（02335）擬於8月28日召開董事會審議2026年中期業績及派息方案

港股異動 | 麥科醫藥-B(02335)升逾3% MT200605臨床前及I期臨床數據獲接納於WSC 2026大會作口頭報告

麥科醫藥(02335.HK)MT200605臨床數據獲接納於WSC 2026作口頭報告

阿斯达克财经

麥科醫藥-B(02335.HK)：MT200605的臨床前及I期臨床數據獲接納於2026年第十八屆世界卒中大會作口頭報告

麥科醫藥－Ｂ(02335)股價上升5.641%，現價港幣$30.34

阿斯达克财经

麥科醫藥－Ｂ(02335)股價下跌5.574%，現價港幣$28.8

阿斯达克财经

麥科醫藥腦梗創新藥II期臨床達主要終點，對標數十億元市場

麥科醫藥-B 2026年7月無新增發行或股份變動

港股異動 | 麥科醫藥-B(02335)升逾3% MT200605治療急性缺血性腦卒中的II期臨床試驗達到主要終點

麥科醫藥(02335.HK)候選藥MT200605臨床試驗達主要終點

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/02335/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02335","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","market":"HK","secType":"STK","nameCN":"麥科醫藥-B","latestPrice":28.42,"timestamp":1787645292941,"preClose":28.32,"halted":0,"volume":265600,"delay":0,"changeRate":0.003531073446327734,"floatShares":280071100,"shares":331740350,"eps":0,"marketStatus":"已收盤","change":0.1,"latestTime":"08-25 16:08:12","open":28.3,"high":28.76,"low":28.06,"amount":7535484,"amplitude":0.024718,"askPrice":28.42,"askSize":400,"bidPrice":28.16,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-0.609,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":5,"adr":0,"listingDate":1782230400000,"exchange":"SEHK","adjPreClose":28.32,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":0.643723,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","floatShares":280071100,"roa":"-33.17%","roe":"--","lyrEps":0,"volumeRatio":0.643723,"shares":331740350,"dividePrice":0,"high":28.76,"amplitude":0.024718,"preClose":28.32,"low":28.06,"week52Low":27,"pbRate":"-8.31","psRate":"27585.63","week52High":45.04,"institutionHeld":0,"latestPrice":28.42,"committee":0.2,"eps":0,"divideRate":0,"volume":265600,"delay":0,"ttmEps":-0.609,"open":28.3,"prevYearClose":18.2,"prevWeekClose":29.36,"prevMonthClose":28.72,"prevQuarterClose":36.54,"fiveDayClose":31.74,"twentyDayClose":28.14,"sixtyDayClose":18.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02335\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02335","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02335\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02335\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02335\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02335","date":"2026-08-24","current":-46.600985,"percent":0.952381,"low":-69.768231,"twenty":-62.850376,"median":-53.390071,"eighty":-45.876641,"high":-30.846573,"avg":-53.470019,"sd":8.908012,"marketCap":9394886712},"quantilePoints":[{"date":"2026-06-26","current":-62.263046,"twenty":-62.206329,"median":-60.152258,"eighty":-47.220229,"marketCap":13110378632},{"date":"2026-07-03","current":-59.036408,"twenty":-61.58898,"median":-58.586203,"eighty":-56.979685,"marketCap":12440263125},{"date":"2026-07-10","current":-67.90436,"twenty":-64.475349,"median":-60.719674,"eighty":-57.773147,"marketCap":14291374278},{"date":"2026-07-17","current":-63.579874,"twenty":-66.545041,"median":-62.752488,"eighty":-58.496163,"marketCap":13428849368},{"date":"2026-07-24","current":-53.390071,"twenty":-65.175311,"median":-60.719674,"eighty":-54.684103,"marketCap":11279171900},{"date":"2026-07-31","current":-45.013396,"twenty":-64.653423,"median":-59.036408,"eighty":-53.47914,"marketCap":9527582852},{"date":"2026-08-07","current":-44.926163,"twenty":-63.868877,"median":-57.071612,"eighty":-46.373695,"marketCap":9527582852},{"date":"2026-08-14","current":-46.337925,"twenty":-63.512285,"median":-53.986784,"eighty":-46.072055,"marketCap":9839418781},{"date":"2026-08-21","current":-45.768087,"twenty":-63.046152,"median":-53.612744,"eighty":-46.072055,"marketCap":9739896676},{"date":"2026-08-24","current":-44.162772,"twenty":-62.850376,"median":-53.390071,"eighty":-45.876641,"marketCap":9394886712}],"updateTime":1787644180742},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02335\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662320734","title":"麥科醫藥-B(02335)存倉市值總計5.21億港元 股東將1773.41萬股股票存入Merrill Lynch Far East","url":"https://stock-news.laohu8.com/highlight/detail?id=2662320734","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662320734?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:07","pubTimestamp":1787620021,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，8月24日，麦科医药-B(02335)出现存仓异动，存仓市值总计5.21亿港元，占比6.33%。该公司股东将1773.41万股股票存入Merrill Lynch Far East。\r\n\r\n　　麦科医药发布公告，根据恒生指数有限公司于2026年8月21日公布的截至2026年6月30日止期间的恒生指数系列季度检讨结果，公司已获选并将纳入为恒生综合指数(恒生综指)成份股，自2026年9月7日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260825/32345698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661240441","title":"麥科醫藥-B(02335)獲納入恒生綜合指數成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661240441","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661240441?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 12:11","pubTimestamp":1787544686,"startTime":"0","endTime":"0","summary":"智通财经APP讯，麦科医药-B(02335)发布公告，根据恒生指数有限公司于2026年8月21日公布的截至2026年6月30日止期间的恒生指数系列季度检讨结果，本公司已获选并将纳入为恒生综合指数(恒生综指)成份股，自2026年9月7日起生效。于获纳入恒生综指成份股后，本公司H股预期将符合资格获纳入沪港通及深港通。沪港通及深港通是香港与中国内地资本市场投资者进行股票交易及投资的渠道。董事会相信，获纳入恒生综指反映资本市场对本公司价值及成长潜力的认可，这将有助于拓宽本公司股东基础及提升其H股的交易流动性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484048.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02335","BK1161","HSCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105527001","title":"麥科醫藥-B（02335）將於9月7日納入恒生綜合指數","url":"https://stock-news.laohu8.com/highlight/detail?id=1105527001","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105527001?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 12:05","pubTimestamp":1787544330,"startTime":"0","endTime":"0","summary":"麦科医药-B（02335）8月24日公告称，根据恒生指数有限公司在2026年8月21日公布的截至2026年6月30日止期间恒生指数系列季度检讨结果，公司H股将被纳入恒生综合指数，生效日期为2026年9月7日。\n公司表示，纳入恒生综合指数后，其H股预计将符合资格被纳入沪港通及深港通，为香港与内地资本市场投资者提供交易渠道。\n董事会认为，此次纳指显示资本市场对公司价值及成长潜力的认可，并有助于拓宽股东基础及提升H股交易流动性。\n公司提醒股东及潜在投资者在买卖公司股份时保持审慎。公告由公司主席、首席执行官兼执行董事王冰于2026年8月24日签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140356227","title":"陝西麥科醫藥科技（02335.HK）將於2026年9月7日納入恒生綜合指數","url":"https://stock-news.laohu8.com/highlight/detail?id=1140356227","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140356227?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 12:05","pubTimestamp":1787544313,"startTime":"0","endTime":"0","summary":"陕西麦科医药科技股份有限公司传来重磅消息——该公司将被正式纳入恒生综合指数，这一变动自2026年9月7日起生效。此次将陕西麦科医药科技纳入其中，无疑是对该公司市值、流动性及行业代表性等多方面指标的肯定。总而言之，陕西麦科医药科技即将跻身恒生综合指数成分股行列，这不仅是对其过往经营成果的认可，更预示着其在资本市场新征程上的启航。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660450192","title":"麥科醫藥－Ｂ(02335)股價上升5.145%，現價港幣$31.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2660450192","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660450192?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 15:30","pubTimestamp":1787038200,"startTime":"0","endTime":"0","summary":"[上升股]麦科医药－Ｂ(02335) 股价在下午03:35比前收市价上升5.145%，现股价为港币$31.88。至目前为止，今日最高价为$31.88，而最低价为$31.88。总成交量为400股，总成交金额为港币$1.275万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608182336/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608182336/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660454482","title":"港股異動 | 麥科醫藥-B(02335)午後漲近6% 創新藥XTL6001三登國際頂級學術舞台","url":"https://stock-news.laohu8.com/highlight/detail?id=2660454482","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660454482?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 13:48","pubTimestamp":1787032087,"startTime":"0","endTime":"0","summary":"消息面上，近日，麦科医药自主研发的创新药物XTL6001的肾脏病研究，成功入选2026年美国肾脏病学会肾脏周壁报展示。作为入选国家科技重大专项、斩获FDA孤儿药资质的小分子药物，MT200605凭借独有的全病程三重通路机制，直击国内脑梗治疗核心痛点，有望填补神经保护剂临床空白，重塑心脑血管创新药竞争格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","02335","06978","BK1161","BK4585","BK4588","IBBQ","KCAI","BK1574","LNGR","159992","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660438423","title":"麥科醫藥(02335.HK)XTL6001研究獲接納於公認學術會議作報告","url":"https://stock-news.laohu8.com/highlight/detail?id=2660438423","media":"阿斯达克财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660438423?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 21:22","pubTimestamp":1786972920,"startTime":"0","endTime":"0","summary":"麦科医药－Ｂ(02335.HK) 公布，集团其中一款主要产品XTL6001的研究成果，获接纳于糖尿病、代谢性疾病以及肾脏病领域的多场顶尖国际公认学术会议上作报告，包括第62届欧洲糖尿病研究协会年会“EASD 2026”，以及2026年美国肾脏病学会肾脏周“ASN Kidney Week 2026”。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260615090208913_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260615090208913_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1538785/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1538785/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107177771","title":"麥科醫藥-B（02335）主要產品XTL6001研究成果獲EASD 2026及ASN Kidney Week 2026收錄","url":"https://stock-news.laohu8.com/highlight/detail?id=1107177771","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107177771?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 18:45","pubTimestamp":1786963544,"startTime":"0","endTime":"0","summary":"麦科医药-B8月17日发布自愿性公告称，集团关键产品XTL6001的最新研究成果已获多项国际学术会议接纳并将作报告。EASD 2026将于2026年9月28日至10月2日在意大利米兰举行。此外，集团核心产品MT1013的相关研究成果曾获选于ASN Kidney Week 2025的Late-Breaking Research Posters环节展示。公司表示，XTL6001连续入选ADA、EASD及ASN等国际学术会议，标志着其在体重管理及肾脏病领域的研发进展迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660481420","title":"麥科醫藥-B(02335.HK)：XTL6001的研究獲接納於EASD 2026及ASN KIDNEY WEEK 2026作報告","url":"https://stock-news.laohu8.com/highlight/detail?id=2660481420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660481420?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 18:40","pubTimestamp":1786963221,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659147209","title":"麥科醫藥-B(02335.HK)8月28日舉行董事會會議批准中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2659147209","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659147209?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 22:27","pubTimestamp":1786717626,"startTime":"0","endTime":"0","summary":"格隆汇8月14日丨麦科医药-B(02335.HK)宣布，公司将于2026年8月28日(星期五)举行董事会会议，藉以(其中包括)批准公司及其附属公司截至2026年6月30日止六个月的未经审计中期业绩及其发布，考虑派发中期股息的建议(如有)，以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260814/32335962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124062847","title":"麥科醫藥-B（02335）擬於8月28日召開董事會 審議2026年中期業績及派息方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1124062847","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124062847?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 21:45","pubTimestamp":1786715131,"startTime":"0","endTime":"0","summary":"陕西麦科奥特医药科技股份有限公司（02335）8月14日公告称，公司董事会将于2026年8月28日（星期五）召开会议，主要议程包括：一、审议并批准公司及其附属公司截至2026年6月30日止六个月的未经审计中期业绩及其发布；二、考虑派发中期股息的建议（如有）；三、处理其他事项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658896964","title":"港股異動 | 麥科醫藥-B(02335)升逾3% MT200605臨床前及I期臨床數據獲接納於WSC 2026大會作口頭報告","url":"https://stock-news.laohu8.com/highlight/detail?id=2658896964","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658896964?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 11:39","pubTimestamp":1786419558,"startTime":"0","endTime":"0","summary":"消息面上，8月10日，麦科医药-B发布公告，本集团自主研发的用于治疗急性缺血性脑卒中的注射用神经保护候选药物MT200605的临床前及I期临床数据，已获接纳于2026年第十八届世界卒中大会作口头报告。在MT200605的临床前及I期临床数据获接纳于WSC 2026上作口头报告的同时，MT200605用于急性缺血性脑卒中的II期临床试验已获得具有统计学意义及临床相关性的结果，并达到主要终点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1161","BK4588","02335","BK4129","KCAI","LU1878469433.USD","LU1815336091.USD","VXUS","LU0757428866.USD","WSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658493079","title":"麥科醫藥(02335.HK)MT200605臨床數據獲接納於WSC 2026作口頭報告","url":"https://stock-news.laohu8.com/highlight/detail?id=2658493079","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658493079?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 00:03","pubTimestamp":1786377780,"startTime":"0","endTime":"0","summary":"麦科医药－Ｂ(02335.HK) 公布，集团自主研发用于治疗急性缺血性脑卒中(AIS)的注射用神经保护候选药物MT200605的临床前及I期临床数据，获接纳于2026年第十八届世界卒中大会“WSC 2026”作口头报告。WSC 2026将于10月21日至23日在韩国首尔举行。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260615090208913_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260615090208913_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1537491/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1537491/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658937540","title":"麥科醫藥-B(02335.HK)：MT200605的臨床前及I期臨床數據獲接納於2026年第十八屆世界卒中大會作口頭報告","url":"https://stock-news.laohu8.com/highlight/detail?id=2658937540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658937540?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 22:56","pubTimestamp":1786373772,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658600626","title":"麥科醫藥－Ｂ(02335)股價上升5.641%，現價港幣$30.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2658600626","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658600626?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 13:49","pubTimestamp":1786340940,"startTime":"0","endTime":"0","summary":"[上升股]麦科医药－Ｂ(02335) 股价在下午01:49比前收市价上升5.641%，现股价为港币$30.34。至目前为止，今日最高价为$30.34，而最低价为$28.38。总成交量为52.18万股，总成交金额为港币$1.511千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608101940/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608101940/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657936136","title":"麥科醫藥－Ｂ(02335)股價下跌5.574%，現價港幣$28.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2657936136","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657936136?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 11:00","pubTimestamp":1786071600,"startTime":"0","endTime":"0","summary":"[下跌股]麦科医药－Ｂ(02335) 股价在上午11:00比前收市价下跌5.574%，现股价为港币$28.8。至目前为止，今日最高价为$30.92，而最低价为$28.8。总成交量为24.8万股，总成交金额为港币$749.702万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260807716/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD260807716/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158417515","title":"麥科醫藥腦梗創新藥II期臨床達主要終點，對標數十億元市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1158417515","media":"21财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158417515?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 17:43","pubTimestamp":1785836628,"startTime":"0","endTime":"0","summary":"8月3日晚，麦科医药发布自愿性公告，宣布其自主研发的注射用神经保护候选药物MT200605在治疗急性缺血性脑卒中的II期临床试验中成功达到主要研究终点。截至目前，麦科已有7条管线进入临床，是国内进入临床试验阶段数量最多的多肽创新药企业。据麦科医药介绍，MT200605为自研创新药，通过静脉注射抵达脑组织内部。截至麦科医药上市，共有三种神经保护药物获国家药监局批准。根据公告，此次达到主要终点的II期临床试验共入组360名受试者。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"lsy1653463924952","url":"https://m.21jingji.com/article/20260804/herald/796fe5d0c1bcc58369f83b0c12f3a89f_zaker.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://m.21jingji.com/article/20260804/herald/796fe5d0c1bcc58369f83b0c12f3a89f_zaker.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1653463924952","symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153660594","title":"麥科醫藥-B 2026年7月無新增發行或股份變動","url":"https://stock-news.laohu8.com/highlight/detail?id=1153660594","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153660594?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 16:58","pubTimestamp":1785833884,"startTime":"0","endTime":"0","summary":"陝西麥科奧特醫藥科技股份有限公司于2026年8月4日发布2026年7月股份变动月报表，报告期为截至2026年7月31日。公司注册股本合计为6,634,807元人民币。报告期内，公司及其库藏股数量均未发生变动，H股及内资股发行量分别保持280,071,100股和51,669,250股不变，合计331,740,350股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656401580","title":"港股異動 | 麥科醫藥-B(02335)升逾3% MT200605治療急性缺血性腦卒中的II期臨床試驗達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2656401580","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656401580?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 14:38","pubTimestamp":1785825519,"startTime":"0","endTime":"0","summary":"消息面上，8月3日，麦科医药-B发布公告，本集团自主研发的用于治疗AIS的候选药物MT200605的II期临床试验已获得顶线数据。数据显示，该临床试验已达到其主要研究终点，结果具有统计学显著性及临床意义。除用于治疗急性缺血性脑卒中外，MT200605亦正开发用于治疗亨廷顿舞蹈病。MT200605可选择性激活TrkB 信号通路，同时发挥神经保护及抗氧化双重作用，以保护神经组织的结构及功能。于2026年3月， MT200605针对HD适应症正式获得美国食品药品监督管理局孤儿药认定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BMED","BK4588","02335","PSYK","BK1161","IBBJ","MDTX","IBBQ","BK4585","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656434370","title":"麥科醫藥(02335.HK)候選藥MT200605臨床試驗達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2656434370","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656434370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 23:10","pubTimestamp":1785769800,"startTime":"0","endTime":"0","summary":"麦科医药－Ｂ(02335.HK) 公布，集团自主研发用于治疗AIS的候选药物MT200605的II期临床试验已获得顶线数据。数据显示，该临床试验已达到其主要研究终点，结果具有统计学显著性及临床意义。整体上，MT200605在缺血性脑卒中患者中展现出显著、稳健的疗效，且安全性、耐受性良好。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20260417085517124_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20260417085517124_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1536348/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1536348/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}]}}